Angiogenesis in pancreatic cancer: current research status and clinical implications

Pancreatic cancer is one of the most lethal malignancies worldwide. Although the standard of care in pancreatic cancer has improved, prognoses for patients remain poor with a 5-year survival rate of

Bibliographic Details

Published in:	Angiogenesis (London) 2019-02, Vol.22 (1), p.15-36
Main Authors:	Li, Shuo, Xu, Hua-Xiang, Wu, Chun-Tao, Wang, Wen-Quan, Jin, Wei, Gao, He-Li, Li, Hao, Zhang, Shi-Rong, Xu, Jin-Zhi, Qi, Zi-Hao, Ni, Quan-Xing, Yu, Xian-Jun, Liu, Liang
Format:	Article
Language:	eng
Subjects:	Angiogenesis Angiogenesis Inhibitors - therapeutic use Animals Biomedical and Life Sciences Biomedicine Blood vessels Cancer Cancer Research Cardiology Cell Biology Humans Medical research Metastases Neovascularization, Pathologic - drug therapy Neovascularization, Pathologic - metabolism Neovascularization, Pathologic - pathology Oncology Ophthalmology Pancreatic cancer Pancreatic Neoplasms - blood supply Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - metabolism Pancreatic Neoplasms - pathology Patients Prognosis Review Paper Solid tumors Target recognition Therapeutic applications Tumors
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!